Gilead Sciences, Starbucks, BP, Coty and more

Take a look at some of the most important engines on the previous market:

Gilead Sciences (GILD) – Gilead priced its Covid-19 antiviral treatment remdesivir, with developed world governments paying $ 390 per dose and privately insured patients charging $ 520 per dose.

Intercept Pharmaceuticals (ICPT): The Food and Drug Administration did not approve the company’s treatment for obesity-related liver disease. Intercept said it would meet with the FDA to discuss possible pathways to approval.

Starbucks (SBUX), Coca-Cola (KO): Starbucks and Coca-Cola announced pauses in social media ads, in the latest actions against hate speech on platforms like Facebook (FB) and Twitter (TWTR). Liquor maker Diageo (DEO) and chocolate maker Hershey (HSY) announced similar actions.

BP (BP) – BP announced the sale of its petrochemicals business to UK private chemical company Ineos for $ 5 billion. BP said the move means it has met its $ 15 billion divestment target a year ahead of schedule.

Novartis (NVS) – Novartis withdrew its European approval request for its Xiidra dry eye medication after regulators said its effectiveness had not been proven. The drug is already approved in the U.S. (AMZN) – Amazon and SoftBank of Japan have reached out to Russian conglomerate Sistema on a possible purchase of the Ozon conglomerate’s online retail unit, according to the majority owner of Sistema.

Delta Air Lines (DAL) – Delta will send warnings of possible licenses to some 2,500 pilots, due to the sharp drop in travel demand. Delta also offers some pilots voluntary early retirement.

Boeing (BA) – Recertification flights for Boeing’s 737 Max aircraft will begin today, a significant step as Boeing seeks to return the Max to service.

Coty (COTY) – The cosmetics company will pay $ 200 million for a 20% stake in Kim Kardashian West’s makeup brand. Coty had said earlier this month that he was speaking to Kardashian West about a possible collaboration. It is the second deal Coty has reached with the Kardashian / Jenner family this year as it has taken a 51% stake in Kylie Jenner brands.

BioNTech (BNTX) – Singapore’s Temasek and other investors are injecting $ 250 million into the German biotech firm, by buying shares and convertible securities. BioNTech has a developing Covid-19 vaccine candidate and has said it expects the first clinical data on the vaccine this month or in July.

Under Armor (UAA) – Under Armor said it would end the $ 280 million, 15-year clothing partnership with the University of California, Los Angeles, which it signed with the university in 2016, saying it had not received the marketing benefits. expected for an extended period of time. UCLA said it would fight the move to end the partnership.

Chesapeake Energy (CHK) – Chesapeake Energy filed for Chapter 11 bankruptcy protection, with the natural gas producer saddled with $ 10 billion in debt.

Beyond Meat (BYND): The plant-based burger maker was downgraded to “underweight” from “overweight” at Barclays, pointing to several factors, including the impact of blockages on service channels. foods.

General Motors (GM): The automaker is delaying a judge’s order to resolve a legal dispute with rival Fiat Chrysler (FCAU) by causing the CEOs of the two companies to meet. GM is seeking to have that order overturned and continue its charge of organized crime against its rival. GM had accused Fiat Chrysler of bribing union officials to gain a labor cost advantage.

Restaurant Brands (QSR): The restaurant operator said demand is picking up as economies re-open in their main markets. Restaurant Brands said Burger King’s comparable sales now tend to be flat, compared to falls in the 30 percent range in mid-March. Comparable sales on its Tim Hortons brand are in the negative teens right now, compared to the negative mid-40s in March.